Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement - Dietrich, Sascha; Schönland, Stefan; Benner, Axel; Bochtler, Tilmann; Kristen, Arnt; Beimler, Jörg; Hund, Ernst; Zorn, Markus; Goldschmidt, Hartmut; Ho, Anthony Dick; Hegenbart, Ute (Blood, 2010)
Gesehen am 07.01.2022